https://orcid.org/0000-0001-5943-5031
Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jaydeo T. Kilbile, Yasinalli Tamboli, Vinod Ahirrao, Ravindra Yeole & Arvind Y. Merwade. (2023) Synthesis, structural characterization of optical isomers and potential impurities in Alalevonadifloxacin mesylate. Synthetic Communications 53:3, pages 234-244.
Read now
Read now
Charul Lautre, Sanjay Sharma & Jagdish K. Sahu. (2022) Chemistry, Biological Properties and Analytical Methods of Levonadifloxacin: A Review. Critical Reviews in Analytical Chemistry 52:5, pages 1069-1077.
Read now
Read now
Chien-Ming Chao, Teng-Song Weng, Yu-Hung Chen, Chih-Cheng Lai & Wei-Ting Lin. (2022) Anti-MRSA quinolones for acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-infective Therapy 20:5, pages 733-739.
Read now
Read now
Xiaohui Huang, Ze Yu, Xin Wei, Junfeng Shi, Yu Wang, Zeyuan Wang, Jihui Chen, Shuhong Bu, Lixia Li, Fei Gao, Jian Zhang & Ajing Xu. (2021) Prediction of vancomycin dose on high-dimensional data using machine learning techniques. Expert Review of Clinical Pharmacology 14:6, pages 761-771.
Read now
Read now
Rajesh Chavan, Vineet Zope, Nilesh Chavan, Javeed Shaikh, Kiran Patil, Ravindra Yeole, Sachin Bhagwat & Mahesh Patel. (2020) Assessment of in vitro inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes. Xenobiotica 50:10, pages 1149-1157.
Read now
Read now
Articles from other publishers (30)
Edward J.A. Douglas & Maisem Laabei. (2023) Staph wars: the antibiotic pipeline strikes back. Microbiology 169:9.
Crossref
Crossref
Shivani Juneja, Rohit Kalia, Ratinder P Singh & Vandana Roy. (2023) Staphylococcus Infections and Emerging Drug Resistance: A Global Concern. Journal of Medical Academics 6:1, pages 20-27.
Crossref
Crossref
Kah Wei Chin, Hui Ling Michelle Tiong, Vijitra Luang-In & Nyuk Ling Ma. (2023) An overview of antibiotic and antibiotic resistance. Environmental Advances 11, pages 100331.
Crossref
Crossref
Swamini Saini, Puranjan Mishra, Mansi Balhara, Debjani Dutta, Shamik Ghosh & Surabhi Chaudhuri. (2023) Antimicrobial potency of Punica granatum peel extract: Against multidrug resistant clinical isolates. Gene Reports 30, pages 101744.
Crossref
Crossref
Balaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Abi Manesh, Binesh Lal, Subramanian Swaminathan, Abdul Ansari, K. Subbareddy, Pradeep Rangappa, Anirban Hom Choudhuri, Vasant Nagvekar, Yatin Mehta, Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, Suchitra Shenoy, Renu Bhardwaj, Vaishali Kongre, Gogi Suresh Dattatraya, Binita Verma, D.N. Mukherjee, Shalini Gupta, Priyadarshini Shanmugam, Jyoti Iravane, Sudhi Ranjan Mishra, Purabi Barman, Shimpi Chopra, Meenakshi Hariharan, Rajendra Surpam, Rana Pratap, Dilip Turbadkar & Shripad Taklikar. (2023) India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care. Indian Journal of Medical Microbiology 41, pages 71-80.
Crossref
Crossref
Anshul SharmaKeshav DhimanAnshul SharmaKamya GoyalVinay PanditM.S. AshawatShammy Jindal. (2022) Fusidic Acid: A Therapeutic Review. Asian Journal of Research in Chemistry, pages 372-380.
Crossref
Crossref
Yatin Mehta, K. C. Mishra, Yashesh Paliwal, Pradeep Rangappa, Sharmili Sinha & Sandeep Bhapkar. (2022) Meeting the Unmet Need in the Management of MDR Gram-Positive Infections with Oral Bactericidal Agent Levonadifloxacin. Critical Care Research and Practice 2022, pages 1-13.
Crossref
Crossref
Manohar Nandanwar, Atul Kansagara, Sangita Gupta, Anasuya Patel, Muftedar Ahmed Patel, Ravindra Yeole, Deepak Thorve & Mahesh Patel. (2022)
Preclinical safety evaluation of levonadifloxacin, a novel anti‐methicillin‐resistant
Staphyloccocus aureus
benzoquinolizine fluoroquinolone by intravenous and oral administration
. Journal of Applied Toxicology 42:8, pages 1354-1370.
Crossref
Crossref
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma L. McInturff, Sarah J. Fink, Subham Mahapatra, Daniel W. Carney, Erick A. Lindsey, Jacob C. DeForest, Scott P. France, Simon Berritt, Simone V. Bigi-Botterill, Tony S. Gibson, Rebecca B. Watson, Yiyang Liu & Christopher J. O’Donnell. (2022) Synthetic Approaches to the New Drugs Approved During 2020. Journal of Medicinal Chemistry 65:14, pages 9607-9661.
Crossref
Crossref
Kathleen Gallo, Andrean Goede, Robert Preissner & Bjoern-Oliver Gohlke. (2022) SuperPred 3.0: drug classification and target prediction—a machine learning approach. Nucleic Acids Research 50:W1, pages W726-W731.
Crossref
Crossref
Rose Herbert, Mary Caddick, Tobi Somerville, Keri McLean, Shakeel Herwitker, Timothy Neal, Gabriela Czanner, Stephen Tuft & Stephen B Kaye. (2022) Potential new fluoroquinolone treatments for suspected bacterial keratitis. BMJ Open Ophthalmology 7:1, pages e001002.
Crossref
Crossref
Vinod K. Ahirrao, Rajiv A. Jadhav, Suyog N. Vaidya, Sachin S. Bhagwat, Ravindra D. Yeole & Mahesh V. Patel. (2022) Ensuring robustness in the quality of antibiotic susceptibility test discs for four novel antibiotics. Biomedical Chromatography 36:6.
Crossref
Crossref
Kapil D Mehta, Jai B Sharma, Ashok Anand, Pavan K Reddy N, Pramod Kadam, Khokan Debnath, Sandeep Bhapkar & Bini M Thampi. (2022) Real-World Evidence of Efficacy and Safety of Levonadifloxacin (Oral and IV) in the Management of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Findings of a Retrospective, Multi-Center Study. Cureus.
Crossref
Crossref
Vipul P. Rane, Rushikesh H. Patil, Kiran R. Patil, Amin R. Pathan, Sukantakumar Naik, Vinod K. Ahirrao, Rajiv A. Jadhav & Ravindra D. Yeole. (2022) Investigation on Impurity Profiling and Degradation Behavior of WCK 771. Chromatographia 85:2, pages 155-165.
Crossref
Crossref
Mrunalini Kalikar. (2022) Levonadifloxacin. Vidarbha Journal of Internal Medicine 32, pages 55-58.
Crossref
Crossref
Yatin Mehta, AnandR Sutar, Kapil Zirpe, JayNarendra Kothari, Chakravarthi Alapati, Manu Pathak, VasantC Nagvekar, KapilDev Mehta & Khokan Debnath. (2022) Prescription-Event monitoring study on safety and efficacy of levonadifloxacin (oral and I.V.) in management of bacterial infections: Findings of real-world observational study. International Journal of Applied and Basic Medical Research 12:1, pages 30.
Crossref
Crossref
Emily N. Drwiega & Keith A. Rodvold. (2021) Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update. Clinical Pharmacokinetics 61:1, pages 17-46.
Crossref
Crossref
Aline Vidal Lacerda Gontijo, Sharlene Lopes Pereira & Herval de Lacerda Bonfante. (2021) Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?. Current Microbiology 79:1.
Crossref
Crossref
Satish Bhawsar, Rajesh Kale, Prasad Deshpande, Ravindra Yeole, Sachin Bhagwat & Mahesh Patel. (2021) Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection. Bioorganic & Medicinal Chemistry Letters 54, pages 128432.
Crossref
Crossref
Jaydeo T. Kilbile, Yasinalli Tamboli, Mohammad Rafeeq, Ram Prasad Yadav, Vipul P. Rane, Vijay S. Bhamare & Arvind Y. Merwade. (2021) Efficient Synthesis of Potential Impurities in Levonadifloxacin (WCK 771). ACS Omega 6:44, pages 29993-30002.
Crossref
Crossref
Zhengzheng Wang, Guoyang Xie, Guanhua Chen, Xingcai Gao, Jiaxin Li, Zongliang Xie & Hengyi Xu. (2021) Triplex PCR combined with magnetic separation strategy for rapid and specific detection of methicillin-resistant Staphylococcus aureus in hospital samples. Microchemical Journal 169, pages 106593.
Crossref
Crossref
Aura Rusu, Ioana-Andreea Lungu, Octavia-Laura Moldovan, Corneliu Tanase & Gabriel Hancu. (2021) Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones—Shaping the Fifth Generation. Pharmaceutics 13:8, pages 1289.
Crossref
Crossref
Firzan Nainu, Andi Dian Permana, Nana Juniarti Natsir Djide, Qonita Kurnia Anjani, Rifka Nurul Utami, Nur Rahma Rumata, Jianye Zhang, Talha Bin Emran & Jesus Simal-Gandara. (2021) Pharmaceutical Approaches on Antimicrobial Resistance: Prospects and Challenges. Antibiotics 10:8, pages 981.
Crossref
Crossref
Nur Najihah Izzati Mat Rani, Zahraa Mustafa Hussein, Fahimi Mustapa, Hanisah Azhari, Mahendran Sekar, Xiang Yi Chen & Mohd Cairul Iqbal Mohd Amin. (2021) Exploring the possible targeting strategies of liposomes against methicillin-resistant Staphylococcus aureus (MRSA). European Journal of Pharmaceutics and Biopharmaceutics 165, pages 84-105.
Crossref
Crossref
Mahesh V. Patel, Sachin S. Bhagwat & Prasad K. Deshpande. 2021. Drug Discovery and Drug Development. Drug Discovery and Drug Development
63
95
.
Dhruv Mamtora, Sanjith Saseedharan, Ritika Rampal, Prashant Joshi, Pallavi Bhalekar, Jaishid Ahdal & Rishi Jain. (2020) In Vitro activity of a Novel Benzoquinolizine Antibiotic, Levonadifloxacin (WCK 771) against Blood Stream Gram-Positive Isolates from a Tertiary Care Hospital. Journal of Laboratory Physicians 12:03, pages 230-232.
Crossref
Crossref
Yilin Wang, Fuyan Xiao & Guofan Jin. (2020) Structural basis of quinolone derivatives, inhibition of type I and II topoisomerases and inquiry into the relevance of bioactivity in odd or even branches with molecular docking study. Journal of Molecular Structure 1221, pages 128869.
Crossref
Crossref
Shrikala Baliga, Dhruv K. Mamtora, Varsha Gupta, Priyadarshini Shanmugam, Sanjay Biswas, D.N. Mukherjee & Suchitra Shenoy. (2020) Assessment of Antibacterial Activity of Levonadifloxacin against Contemporary Gram-positive Clinical Isolates Collected from Various Indian Hospitals using Disk-Diffusion Assay. Indian Journal of Medical Microbiology 38:3-4, pages 307-312.
Crossref
Crossref
Yamuna Devi Bakthavatchalam, Abirami Shankar, Rajeshwari Muniyasamy, John Victor Peter, Zervos Marcus, Hariharan Triplicane Dwarakanathan, Karthik Gunasekaran, Ramya Iyadurai & Balaji Veeraraghavan. (2020) Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital. Journal of Antimicrobial Chemotherapy.
Crossref
Crossref
Yamuna Devi Bakthavatchalam, Shoma Vinay Rao, Barney Isaac, Abi Manesh, Senthur Nambi, Subramanian Swaminathan, Vasanth Nagvekar, Vivek Nangia, Peter Victor John & Balaji Veeraraghavan. (2019) A Comparative Assessment of Clinical, Pharmacological and Antimicrobial Profile of Novel Anti-methicillin-resistant Staphylococcus aureus Agent Levonadifloxacin: Therapeutic Role in Nosocomial and Community Infections. Indian Journal of Medical Microbiology 37:4, pages 478-487.
Crossref
Crossref